Orion Pharma (DHA:ORIONPHARM) Interest Expense : BDT-550 Mil (TTM As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Orion Pharma's interest expense for the three months ended in Mar. 2025 was BDT -60 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was BDT-550 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Orion Pharma's Operating Income for the three months ended in Mar. 2025 was BDT 69 Mil. Orion Pharma's Interest Expense for the three months ended in Mar. 2025 was BDT -60 Mil. Orion Pharma's Interest Coverage for the quarter that ended in Mar. 2025 was 1.15. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orion Pharma Interest Expense Historical Data

The historical data trend for Orion Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Interest Expense Chart

Orion Pharma Annual Data

Trend

Dec14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Interest Expense

Get a 7-Day Free Trial

-717.02

-223.44

-173.23

-148.29

-393.38

Orion Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-51.17	-314.18	-55.00	-120.64	-59.87

Orion Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-550 Mil.

Orion Pharma (DHA:ORIONPHARM) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orion Pharma's Interest Expense for the three months ended in Mar. 2025 was BDT-60 Mil. Its Operating Income for the three months ended in Mar. 2025 was BDT69 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was BDT23,169 Mil.

Orion Pharma's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	68.731	/	-59.865
	=	1.15

The higher the ratio, the stronger the company's financial strength is.

Orion Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208

Website

https://www.orionpharmabd.com

Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines